Longitudinal Study of Serum Lipids and Liver Enzymes in Workers With Occupational Exposure to Ammonium Perfluorooctanoate

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Occupational and Environmental Medicine

• Publication date

  2007-08-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1097/JOM.0b013e318124a93fPMID 17693785
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Community Exposure to Perfluorooctanoate: Relationships Between Serum Levels and Certain Health Parameters

  2006cited by this paper
• Calculated low density lipoprotein cholesterol levels frequently underestimate directly measured low density lipoprotein cholesterol determinations in patients with serum triglyceride levels < or =4.52 mmol/l: an analysis comparing the LipiDirect magnetic LDL assay with the Friedewald calculation.

  2006cited by this paper
• Absorption, Distribution, and Excretion of Ammonium Perfluorooctanoate (APFO) After Oral Administration to Various Species

  2006cited by this paper
• Historical Comparison of Perfluorooctanesulfonate, Perfluorooctanoate, and Other Fluorochemicals in Human Blood

  2005cited by this paper
• The Toxicology of Perfluorooctanoate

  2004cited by this paper
• A pilot study on the determination of perfluorooctanesulfonate and other perfluorinated compounds in blood of Canadians.

  2004cited by this paper
• Serum concentrations of perfluorooctanesulfonate and other fluorochemicals in an elderly population from Seattle, Washington.

  2004cited by this paper
• The Influence of Time, Sex and Geographic Factors on Levels of Perfluorooctane Sulfonate and Perfluorooctanoate in Human Serum over the Last 25 years

  2004cited by this paper
• Quantitative Evaluation of Perfluorooctanesulfonate (PFOS) and Other Fluorochemicals in the Serum of Children

  2004cited by this paper
• Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries.

  2004cited by this paper
• [Alcoholic liver disease].

  2003cited by this paper
• Epidemiologic Assessment of Worker Serum Perfluorooctanesulfonate (PFOS) and Perfluorooctanoate (PFOA) Concentrations and Medical Surveillance Examinations

  2003cited by this paper
• Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors.

  2003cited by this paper
• Binding of perfluorooctanoic acid to rat and human plasma proteins.

  2003cited by this paper
• Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management, 7th Edition, Vols. 1 and 2.

  2003cited by this paper
• Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation.

  2002cited by this paper
• Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months.

  2002cited by this paper
• PLASMA CHOLECYSTOKININ AND HEPATIC ENZYMES, CHOLESTEROL AND LIPOPROTEINS IN AMMONIUM PERFLUOROOCTANOATE PRODUCTION WORKERS

  2000cited by this paper
• Accuracy of Calculated Serum Low-Density Lipoprotein Cholesterol for the Assessment of Coronary Heart Disease Risk in NIDDM Patients

  1998cited by this paper
• An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid.

  1998cited by this paper
• A more valid measurement of low-density lipoprotein cholesterol in diabetic patients.

  1997cited by this paper
• Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins, and cholesterol: a study of occupationally exposed men.

  1996cited by this paper
• Calculated Low-Density Lipoprotein Cholesterol Should Not Be Used for Management of Lipoprotein Abnormalities in Patients With Diabetes Mellitus

  1993cited by this paper
• The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid.

  1992cited by this paper
• Measurement of low-density-lipoprotein cholesterol in serum: a status report.

  1992cited by this paper
• Lack of evidence for perfluorodecanoyl- or perfluorooctanoyl-coenzyme A formation in male and female rats.

  1992cited by this paper
• Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats.

  1991cited by this paper
• Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk.

  1990cited by this paper
• Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints.

  1990cited by this paper
• Biochemical and morphological studies of ammonium perfluorooctanoate-induced hepatomegaly and peroxisome proliferation.

  1987cited by this paper
• Health status of plant workers exposed to fluorochemicals--a preliminary report.

  1980influential reference

• PFOA induced metabolic and immune perturbations in a SARS-2 infection model

  2026cites this paper
• From Exposure to Dysfunction: The Intestinal Toxicity of Per- and Polyfluoroalkyl Substances

  2025influential citation
• Exposure to a PFAS mixture alters cholesterol lipoprotein subfractions and induces a foam cell-like aortic macrophage expression profile in hyperlipidemic LDLr-/- mice.

  2025cites this paper
• Per- and polyfluoroalkyl substances (PFAS) in the United States: Current knowledge and regulatory context.

  2025cites this paper
• Per- and Polyfluoroalkyl Substances Induces Salt-Sensitive Hypertension by Upregulating Epithelial Sodium Channel - The First Experimental Evidence Supporting Causality

  2025cites this paper
• The relationship between PFAS exposure and dyslipidemia: an updated review, meta-analysis, and evaluation of bias

  2025cites this paper
• Understanding the Plastic-associated Endocrine-Disrupting Chemicals in India: Environmental Contamination, Health Impacts and Regulatory Challenges

  2025cites this paper
• Associations of per- and perfluoroalkyl substances with serum alanine and aspartate aminotransferase levels and the potential mediating role of cytokines in Children.

  2025cites this paper
• Per- and polyfluorinated substances (PFAS) promote osteoclastogenesis and bone loss through PPARα activation

  2025cites this paper
• Identification of four mechanisms of toxicity for per- and polyfluoroalkyl substances through transcriptomic profiling in human liver spheroids exposed to 24 PFAS

  2025cites this paper
• A Critical Review of Populations with Occupational Exposure to Per- and Polyfluoroalkyl Substances: External Exposome, Internal Exposure Levels, and Health Effects.

  2025cites this paper
• The role of per‐ and polyfluoroalkyl substances in cognitive impairment and dementia

  2025cites this paper
• Temporal and cross-sectional associations of serum per- and polyfluoroalkyl substances (PFAS) and lipids from 1986 to 2016 - The Tromsø study.

  2025cites this paper
• Perfluorooctanoic acid increases serum cholesterol in a PPARα-dependent manner in female mice

  2025cites this paper
• Longitudinal association of Perfluorooctanoic Acid (PFOA) and Perfluorooctanesulphonic Acid (PFOS) exposure with lipid traits, in a healthy unselected population

  2025cites this paper
• The perils of poly- and perfluorinated chemicals on the reproductive health of humans, livestock, and wildlife.

  2024cites this paper
• Specific and potent inhibition of steroid hormone pre-receptor regulator AKR1C2 by perfluorooctanoic acid: implications for androgen metabolism.

  2024cites this paper
• Exploring the sources, occurrence, transformation, toxicity, monitoring, and remediation strategies of per- and polyfluoroalkyl substances: a review

  2024cites this paper
• Decreases in serum PFAS are associated with decreases in serum lipids: A longitudinal study on a highly exposed population.

  2024cites this paper
• Exposure of Ldlr−/− Mice to a PFAS Mixture and Outcomes Related to Circulating Lipids, Bile Acid Excretion, and the Intestinal Transporter ASBT

  2024cites this paper
• The long-chain polyfluorinated alkyl substance perfluorohexane sulfonate (PFHxS) promotes bone marrow adipogenesis.

  2024cites this paper
• Mechanisms of colon toxicity induced by long-term perfluorooctanoic acid exposure in mice.

  2024cites this paper
• Association between per- and polyfluoroalkyl substances with serum hepatobiliary system function biomarkers in patients with acute coronary syndrome.

  2024cites this paper
• Assessing the performance of a targeted absolute quantification isotope dilution liquid chromatograhy tandem mass spectrometry assay versus a commercial nontargeted relative quantification assay for detection of three major perfluoroalkyls in human blood.

  2024cites this paper
• Effect of lifestyle-based lipid lowering interventions on the relationship between circulating levels of per-and polyfluoroalkyl substances and serum cholesterol.

  2023cites this paper
• Overall and individual associations between per- and polyfluoroalkyl substances and liver function indices and the metabolic mechanism.

  2023cites this paper
• Per- and Polyfluoroalkyl Substances (PFAS) and Lipid Trajectories in Women 45–56 Years of Age: The Study of Women’s Health Across the Nation

  2023cites this paper
• Range of the perfluorooctanoate (PFOA) safe dose for human health: An international collaboration.

  2023cites this paper
• Plasma levels of per- and polyfluoroalkyl substances (PFAS) and cardiovascular disease - Results from two independent population-based cohorts and a meta-analysis.

  2023cites this paper
• Temporal decline in serum PFAS concentrations among metropolitan firefighters: Longitudinal study on post-exposure changes following PFAS foam cessation.

  2023cites this paper
• Per-and polyfluoroalkyl substances (PFAS) as a health hazard: Current state of knowledge and strategies in environmental settings across Asia and future perspectives

  2023cites this paper
• A critical review on the bioaccumulation, transportation, and elimination of per- and polyfluoroalkyl substances in human beings

  2023cites this paper
• Firefighters and the liver: Exposure to PFAS and PAHs in relation to liver function and serum lipids (CELSPAC-FIREexpo study).

  2023cites this paper
• Toxic effects of perfluorocaproic acid (PFHxA) on crucian carp (Carassius auratus) and the response of the intestinal microbial community.

  2023cites this paper
• Sex-specific effect of perfluoroalkyl substances exposure on liver and thyroid function biomarkers: A mixture approach.

  2023cites this paper
• Perfluorooctanoic Acid (PFOA) Exposure and Abnormal Alanine Aminotransferase: Using Clinical Consensus Cutoffs Compared to Statistical Cutoffs for Abnormal Values

  2023cites this paper
• Associations between Per- and Polyfluoroalkyl Substances Exposures and Blood Lipid Levels among Adults—A Meta-Analysis

  2023cites this paper
• Occupational exposure to per- and polyfluoroalkyl substances: a scope review of the literature from 1980–2021

  2023cites this paper
• Per- and Polyfluoroalkyl Substances and Outcomes Related to Metabolic Syndrome: A Review of the Literature and Current Recommendations for Clinicians

  2023cites this paper
• Liver and cardiometabolic markers and conditions in a cross-sectional study of three Australian communities living with environmental per- and polyfluoroalkyl substances contamination.

  2023cites this paper
• Role of bioavailability and protein binding of four anionic perfluoroalkyl substances in cell-based bioassays for quantitative in vitro to in vivo extrapolations.

  2023cites this paper
• Association between maternal exposure to per- and polyfluoroalkyl substances and serum markers of liver function during pregnancy in China: A mixture-based approach.

  2023cites this paper
• Historical Trend of Exposure to Perfluoroalkyl Surfactants PFOA, ADV, and cC6O4 and its Management in Two Perfluoroalkyl Polymers Plants, Italy

  2023influential citation
• PFAS Experts Symposium 2: PFAS Toxicology and Risk Assessment in 2021 and risk assessment in 2021—Contemporary issues in human and ecological risk assessment of PFAS

  2022cites this paper
• Perfluoroalkyl Substance Serum Concentrations and Cholesterol Absorption-Inhibiting Medication Ezetimibe

  2022cites this paper
• Associations between serum perfluoroalkyl acid (PFAA) concentrations and health related biomarkers in firefighters.

  2022cites this paper
• Perfluoroalkyl substances and lipid concentrations in the blood: A systematic review of epidemiological studies.

  2022cites this paper
• Exposure to per- and Polyfluoroalkyl Substances and Markers of Liver Injury: A Systematic Review and Meta-Analysis

  2022cites this paper
• Official health communications are failing PFAS-contaminated communities

  2022cites this paper
• Current and future federal and state sampling guidance for per- and polyfluoroalkyl substances in environmental matrices.

  2022cites this paper
• Associations of serum PFOA and PFOS levels with incident hypertension risk and change of blood pressure levels.

  2022cites this paper
• Perfluoroalkyl substance mixtures and cardio-metabolic outcomes in highly exposed male workers in the Veneto Region: A mixture-based approach.

  2022cites this paper
• Assessment of the Emerging Threat Posed by Perfluoroalkyl and Polyfluoroalkyl Substances to Male Reproduction in Humans

  2022cites this paper
• Changes in plasma levels of per- and polyfluoroalkyl substances (PFAS) are associated with changes in plasma lipids - A longitudinal study over 10 years.

  2022cites this paper
• Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?

  2021influential citation
• Per- and Polyfluoroalkyl Substances (PFAS): Significance and Considerations within the Regulatory Framework of the USA

  2021cites this paper
• Quality assurance and quality control of solid phase extraction for PFAS in water and novel analytical techniques for PFAS analysis.

  2021cites this paper
• The effects of Cl-PFESAs exposure on blood lipids - A community-based large population study in Guangzhou.

  2021cites this paper
• Organofluorine Mass Balance Analysis of Whole Blood Samples in Relation to Gender and Age

  2021cites this paper
• Exposure to a mixture of legacy, alternative, and replacement per- and polyfluoroalkyl substances (PFAS) results in sex-dependent modulation of cholesterol metabolism and liver injury.

  2021cites this paper
• Perfluoroalkyl Chemicals and Neurological Disorders: From Exposure to Preventive Interventions

  2021cites this paper
• N-Acetyl cysteine abates hepatorenal toxicities induced by perfluorooctanoic acid exposure in male rats.

  2021cites this paper
• N‐acetyl cysteine co‐treatment abates perfluorooctanoic acid‐induced reproductive toxicity in male rats

  2021cites this paper
• Per- and polyfluoroalkyl substances and blood pressure in pre-diabetic adults-cross-sectional and longitudinal analyses of the diabetes prevention program outcomes study.

  2020cites this paper
• Diet as an Exposure Source and Mediator of Per- and Polyfluoroalkyl Substance (PFAS) Toxicity

  2020cites this paper
• Uptake, accumulation and metabolism of PFASs in plants and health perspectives: A critical review

  2020cites this paper
• PFAS concentration during pregnancy in relation to cardiometabolic health and birth outcomes.

  2020cites this paper
• Per‐ and Polyfluoroalkyl Substance Toxicity and Human Health Review: Current State of Knowledge and Strategies for Informing Future Research

  2020cites this paper
• Associations between perfluoroalkyl substances and lipid profile in a highly exposed young adult population in the Veneto Region.

  2020cites this paper
• Review: Evolution of evidence on PFOA and health following the assessments of the C8 Science Panel.

  2020cites this paper
• Perfluoroalkyl chemicals in neurological health and disease: Human concerns and animal models.

  2020cites this paper
• Selective Associations of Recent Low Concentrations of Perfluoroalkyl Substances With Liver Function Biomarkers: NHANES 2011 to 2014 Data on US Adults Aged ≥20 Years

  2019cites this paper
• Associations between repeated measure of plasma perfluoroalkyl substances and cardiometabolic risk factors.

  2019cites this paper
• Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice

  2019cites this paper
• Using 2003-2014 U.S. NHANES data to determine the associations between per- and polyfluoroalkyl substances and cholesterol: Trend and implications.

  2019cites this paper
• Liver function biomarkers disorder is associated with exposure to perfluoroalkyl acids in adults: Isomers of C8 Health Project in China.

  2019cites this paper
• Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study.

  2019cites this paper
• The long-term rapid increase in incidence of adenocarcinoma of the kidney in the USA, especially among younger ages.

  2019cites this paper
• Sex differences in the association between perfluoroalkyl acids and liver function in US adolescents: Analyses of NHANES 2013-2016.

  2019cites this paper
• The association between perfluoroalkyl substances and lipids in cord blood.

  2019cites this paper
• Regulation of Perfluorooctanoic Acid (PFOA) and Perfluorooctane Sulfonic Acid (PFOS) in Drinking Water: A Comprehensive Review

  2019cites this paper
• Stochastic Pharmacokinetic-Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA)

  2018cites this paper
• Changes in markers of liver function in relation to changes in perfluoroalkyl substances - A longitudinal study.

  2018cites this paper
• Re: Health Status of Workers Exposed to Perfluorinated Alkylate Substances.

  2018cites this paper
• Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food

  2018cites this paper
• Perfluoroalkyl Substances in the Environment

  2018cites this paper
• Differences in Exposure to Perfluorocarbons and Renal and Liver Function among Foreign-Born U.S. Residents

  2018influential citation
• Early life exposure to per- and polyfluoroalkyl substances and mid-childhood lipid and alanine aminotransferase levels.

  2018influential citation
• Perfluorooctane sulfonate precursors as indirect sources of internal exposure to perfluorooctane sulfonate (PFOS)

  2018cites this paper
• Identification of metabolic profiles associated with human exposure to perfluoroalkyl substances

  2018cites this paper
• Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community.

  2017cites this paper
• PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.

  2017cites this paper
• Circulating levels of perfluoroalkyl substances (PFASs) and carotid artery atherosclerosis

  2017cites this paper
• Removal of perfluorinated compounds from wastewaters by electrochemical methods: A general review

  2017cites this paper
• Lessons Learned from Legacy Contaminants of Emerging Concern: Perfluoroalkyl Compounds (PFCs) in the Village of Hoosick Falls, Rensselaer County, New York

  2017cites this paper
• Global distribution of perfluorochemicals (PFCs) in potential human exposure source-A review.

  2017cites this paper
• Protocol and Analysis Plan

  2017cites this paper
• Title Modeled Perfluorooctanoic Acid ( PFOA ) Exposure and Liver Function in a Mid-Ohio Valley Community Permalink

  2016influential citation
• Health Effects Support Document for Perfluorooctane Sulfonate (PFOS)

  2016cites this paper
• Modeled Perfluorooctanoic Acid (PFOA) Exposure and Liver Function in a Mid-Ohio Valley Community

  2016cites this paper